# PALIPERIDONE PALMITATE
> **ANDA215682** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMACEUTICALS INC A VIATRIS CO · Approved 2024-12-03
## Drug
- **FDA Application Number:** ANDA215682
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALIPERIDONE PALMITATE
- **Generic name:** Paliperidone Palmitate
- **Active ingredients:** PALIPERIDONE PALMITATE
- **Dosage form:** INJECTION
- **Route:** SUSPENSION
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN PHARMACEUTICALS INC A VIATRIS CO
- **First approval:** 2024-12-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215682)
---
*MORVS · CC0 1.0*